Annual CFI
-$7.35 M
+$17.58 M+70.51%
31 December 2023
Summary:
Taysha Gene Therapies annual cash flow from investing activities is currently -$7.35 million, with the most recent change of +$17.58 million (+70.51%) on 31 December 2023. During the last 3 years, it has risen by +$1.73 million (+19.05%). TSHA annual CFI is now at all-time high.TSHA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$35.00 K
+$166.00 K+82.59%
30 September 2024
Summary:
Taysha Gene Therapies quarterly cash flow from investing activities is currently -$35.00 thousand, with the most recent change of +$166.00 thousand (+82.59%) on 30 September 2024. Over the past year, it has increased by +$3.46 million (+99.00%). TSHA quarterly CFI is now -172.92% below its all-time high of $48.00 thousand, reached on 30 June 2023.TSHA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$386.00 K
+$3.46 M+89.95%
30 September 2024
Summary:
Taysha Gene Therapies TTM cash flow from investing activities is currently -$386.00 thousand, with the most recent change of +$3.46 million (+89.95%) on 30 September 2024. Over the past year, it has increased by +$9.33 million (+96.03%).TSHA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +70.5% | +99.0% | +96.0% |
| 3 y3 years | +19.1% | +99.1% | +98.0% |
| 5 y5 years | - | - | - |
TSHA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +70.5% | -172.9% | +99.7% | at high | +98.8% |
| 5 y | 5 years | at high | +70.5% | -172.9% | +99.7% | +98.8% | |
| alltime | all time | at high | +70.5% | -172.9% | +99.7% | <-9999.0% | +98.8% |
Taysha Gene Therapies Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$35.00 K(-82.6%) | -$386.00 K(-90.0%) |
| June 2024 | - | -$201.00 K(+43.6%) | -$3.84 M(+6.9%) |
| Mar 2024 | - | -$140.00 K(+1300.0%) | -$3.59 M(-51.1%) |
| Dec 2023 | -$7.35 M(-70.5%) | -$10.00 K(-99.7%) | -$7.35 M(-24.3%) |
| Sept 2023 | - | -$3.49 M(-7370.8%) | -$9.71 M(+5.1%) |
| June 2023 | - | $48.00 K(-101.2%) | -$9.24 M(-46.9%) |
| Mar 2023 | - | -$3.90 M(+64.6%) | -$17.40 M(-30.2%) |
| Dec 2022 | -$24.93 M | -$2.37 M(-21.5%) | -$24.93 M(-19.8%) |
| Sept 2022 | - | -$3.02 M(-62.8%) | -$31.08 M(-3.1%) |
| June 2022 | - | -$8.11 M(-29.0%) | -$32.06 M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$11.43 M(+34.1%) | -$32.45 M(+50.5%) |
| Dec 2021 | -$21.55 M(+137.3%) | -$8.52 M(+112.9%) | -$21.55 M(+12.9%) |
| Sept 2021 | - | -$4.00 M(-52.9%) | -$19.09 M(+26.3%) |
| June 2021 | - | -$8.50 M(+1491.4%) | -$15.11 M(+57.2%) |
| Mar 2021 | - | -$534.00 K(-91.2%) | -$9.62 M(+5.9%) |
| Dec 2020 | -$9.08 M | - | - |
| Dec 2020 | - | -$6.05 M(>+9900.0%) | -$9.08 M(+199.6%) |
| Sept 2020 | - | -$31.00 K(-99.0%) | -$3.03 M(+1.0%) |
| June 2020 | - | -$3.00 M(<-9900.0%) | -$3.00 M(<-9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
FAQ
- What is Taysha Gene Therapies annual cash flow from investing activities?
- What is the all time high annual CFI for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual CFI year-on-year change?
- What is Taysha Gene Therapies quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly CFI year-on-year change?
- What is Taysha Gene Therapies TTM cash flow from investing activities?
- What is the all time high TTM CFI for Taysha Gene Therapies?
- What is Taysha Gene Therapies TTM CFI year-on-year change?
What is Taysha Gene Therapies annual cash flow from investing activities?
The current annual CFI of TSHA is -$7.35 M
What is the all time high annual CFI for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual cash flow from investing activities is -$7.35 M
What is Taysha Gene Therapies annual CFI year-on-year change?
Over the past year, TSHA annual cash flow from investing activities has changed by +$17.58 M (+70.51%)
What is Taysha Gene Therapies quarterly cash flow from investing activities?
The current quarterly CFI of TSHA is -$35.00 K
What is the all time high quarterly CFI for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly cash flow from investing activities is $48.00 K
What is Taysha Gene Therapies quarterly CFI year-on-year change?
Over the past year, TSHA quarterly cash flow from investing activities has changed by +$3.46 M (+99.00%)
What is Taysha Gene Therapies TTM cash flow from investing activities?
The current TTM CFI of TSHA is -$386.00 K
What is the all time high TTM CFI for Taysha Gene Therapies?
Taysha Gene Therapies all-time high TTM cash flow from investing activities is $0.00
What is Taysha Gene Therapies TTM CFI year-on-year change?
Over the past year, TSHA TTM cash flow from investing activities has changed by +$9.33 M (+96.03%)